RedHill Biopharma (RDHL) Leases: 2011-2025
Historic Leases for RedHill Biopharma (RDHL) over the last 5 years, with Jun 2025 value amounting to $163,000.
- RedHill Biopharma's Leases fell 65.25% to $163,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $163,000, marking a year-over-year decrease of 65.25%. This contributed to the annual value of $302,000 for FY2024, which is 69.46% down from last year.
- According to the latest figures from Q2 2025, RedHill Biopharma's Leases is $163,000, which was down 46.03% from $302,000 recorded in Q4 2024.
- In the past 5 years, RedHill Biopharma's Leases registered a high of $7.7 million during Q1 2022, and its lowest value of $163,000 during Q2 2025.
- For the 3-year period, RedHill Biopharma's Leases averaged around $1.7 million, with its median value being $729,000 (2023).
- Per our database at Business Quant, RedHill Biopharma's Leases surged by 83.29% in 2022 and then plummeted by 85.22% in 2023.
- Over the past 5 years, RedHill Biopharma's Leases (Quarterly) stood at $3.7 million in 2021, then soared by 83.29% to $6.7 million in 2022, then crashed by 85.22% to $989,000 in 2023, then slumped by 69.46% to $302,000 in 2024, then tumbled by 65.25% to $163,000 in 2025.
- Its Leases was $163,000 in Q2 2025, compared to $302,000 in Q4 2024 and $469,000 in Q2 2024.